Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
暂无分享，去创建一个
H. Deeg | D. Maloney | E. Warren | R. Lynch | M. Shadman | C. Ujjani | B. Scott | A. Gopal | Stephen D. Smith | A. Shustov | L. Soma | B. Till | A. Halpern | M. Shadman | J. Cooper | Sirin Khajaviyan | Jason P. Cooper